$FMS News
Last published 3w ago
- 3w agoFMSFresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™PR NewswireExpands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S.FDA clearance of multiFiltratePRO and approval of dedicated solutions expand continuous
- 3w agoFMSFresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026PR NewswireNew U.S. real-world evidence demonstrates high-volume hemodiafiltration (HvHDF) can be successfully delivered in routine clinical practice, with treatment targets comparable to those reported in EuropeGLP-1 receptor
- 1y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, Affirmed-in-PartUS Patent Trial and Appeal Board
- 1y agoBBYFMSGIPRGeneration Income Properties Secures Early Best Buy Lease Extension, Highlighting Tenant Commitment at an Increased Rent; Provides Update on Chicago Property AgreementACCESS NewswireTAMPA, FL / ACCESS Newswire / August 20, 2025 / Generation Income Properties, Inc. , announced the successful execution of a long-term lease extension with Best
- 1y agoFMSGIPRMDVGeneration Income Properties Announces Q2 2025 Financial and Operating ResultsACCESS NewswireTAMPA, FL / ACCESS Newswire / August 15, 2025 / Generation Income Properties, Inc. today announced its three-month financial and operating results for the
- 1y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoFMSFresenius Medical Care AG (FMS) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoFMSApproval of Intralipid 10%, Nda #017643 (Labeling)FDA Approved DrugsApproval Date: 07/24/2025; Drug Name: Intralipid 10%, Nda #017643; Active Ingredients: SOYBEAN OIL; Company: Fresenius; Submission Status: Approval; Submission Classification: Labeling; Application Number: 017643
- 1y agoFMSApproval of Intralipid 30%, Nda #019942 (Labeling)FDA Approved DrugsApproval Date: 07/24/2025; Drug Name: Intralipid 30%, Nda #019942; Active Ingredients: SOYBEAN OIL; Company: Fresenius; Submission Status: Approval; Submission Classification: Labeling; Application Number: 019942
- 1y agoFMSApproval of Intralipid 20%, Nda #018449 (Labeling)FDA Approved DrugsApproval Date: 07/24/2025; Drug Name: Intralipid 20%, Nda #018449; Active Ingredients: SOYBEAN OIL; Company: Fresenius; Submission Status: Approval; Submission Classification: Labeling; Application Number: 018449
- 1y agoFMSApproval of Intralipid 20%, Nda #020248 (Labeling)FDA Approved DrugsApproval Date: 07/24/2025; Drug Name: Intralipid 20%, Nda #020248; Active Ingredients: SOYBEAN OIL; Company: Fresenius; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020248
- 1y agoFMSDGXFresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest DiagnosticsPR NewswireFresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest...
- 1y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, ReversedUS Patent Trial and Appeal Board
- 2y agoFMSFresenius Medical Care AG (FMS) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoFMSFresenius Medical Care AG (FMS) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoFMSFresenius Medical Care AG (FMS) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 2y agoFMSFresenius Medical Care AG (FMS) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoFMSFresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoFMSCapital Square Delivers 149.59% Total Return* to Investors in Medical Building DSTPR NewswireCapital Square, one of the nation's leading sponsors of tax-advantaged real estate investments and an active developer and manager of multifamily...
- 3y agoNOVO.B-DKLLYDVAFMS+11Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and moreCNBCThese are some of the stocks posting the largest moves midday.
- 3y agoFMSCapital Square Delivers 147.63% Total Return* to Investors in Medical Building DSTPR NewswireKINSTON, N.C., Oct. 11, 2023 /PRNewswire/ -- Capital Square, one of the nation's leading sponsors of tax-advantaged real estate investments and an active developer of multifamily communities, announced today the sale
- 3y agoFMSFresenius Medical Care Announces FDA Clearance of Versi®HD with GuideMe SoftwarePR NewswireWALTHAM, Mass., Aug. 23, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the U.S. Food and Drug Administration
- 3y agoFMSFresenius Medical Care successfully executes strategic plan and narrows guidance range due to strong operational performance in the first half of 2023PR NewswireOrganic growth accelerated in the second quarter in Care Enablement and Care Delivery including sequentially stable treatment volumes in the U.S.Execution on turnaround plan translates into visible productivity
- 3y agoFMSFresenius Medical Care simplifies corporate structure by converting into a German stock corporationPR NewswireExtraordinary General Meeting approves conversion of Fresenius Medical Care's legal formSeveral advantages including faster and more agile decision-makingMichael Sen elected as Chair of new Supervisory
- 3y agoFMSFresenius Medical Care appoints Martin Fischer as Chief Financial OfficerPR NewswireUnder the U.S. Securities Act of 1933, as amended (the "Securities Act"), this press release may be deemed to be offering material of Fresenius Medical Care AG & Co. KGaA ("FME"). FME has filed a
- 3y agoFMSInnovative Home Dialysis Training Unit Opens at Indianapolis Fresenius Kidney Care LocationPR NewswireFirst-of-its-kind training program prepares dialysis patients for home therapy WALTHAM, Mass. , March 22, 2023 /PRNewswire/ -- Since the new year began, Ms. Bailey-Wilson has been counting down the days until spring
- 3y agoFMSFresenius Kidney Care Reunites with Food Is Medicine Coalition on Mission to Expand Access to Medically Tailored MealsPR NewswireFresenius Kidney Care Funds National Accreditation and Accelerator Program for More Than 40 Nonprofit Medically Tailored Food and Nutrition Service Providers Across the U.S. With $150,000 Donation WALTHAM, Mass., March
- 3y agoFMSFresenius Kidney Care Renews Commitment to Kidney Health Education with Second Year Boys & Girls Clubs of America National PartnershipPR NewswirePartnership Supports the Clubs' Healthy Habits Program and National Days of Advocacy Event WALTHAM, Mass., March 6, 2023 /PRNewswire/ -- Fresenius Kidney Care, the nation's leader in kidney care services and
- 3y agoFMSFresenius Medical Care takes action to close global health gaps, signs "Zero Health Gaps" Pledge at the World Economic ForumPR NewswireWALTHAM, Mass., Jan. 20, 2023 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has taken the Zero Health Gaps Pledge at the
- 3y agoFMSFresenius Medical Care North America, IKONA Health Receive Major Grant to Expand Virtual Reality Healthcare Education, Improve Access in Rural MississippiPR NewswireGrant allows partners to expand kidney disease education project to rural Mississippi patientsFMCNA implementing virtual reality education in other statesWALTHAM, Mass., Jan. 5, 2023 /PRNewswire/ -- Fresenius Medical
- 4y agoFMSFDA Roundup: October 28, 2022FDA Press ReleasesToday, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA updated the list of Breakthrough Devices that have been authorized for marketing. The list includes 56 Breakthrough Devices that the FDA has authorized for marketing. Online metrics show the number of granted Breakthrough Device designations by fiscal year and by clinical ...
- 4y agoFMSFresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE AwardPR NewswireThe CARE Award Honors Frontline Nephrology Care Team Members for Embodying the Company's Core Values WALTHAM, Mass., Sept. 12, 2022 /PRNewswire/ -- Fresenius Kidney Care, the nation's leading provider of kidney care services, is pleased to announce its
- 4y agoFMSFresenius Medical Care Wins Major Award to Support U.S. Veterans with Industry-Leading Dialysis CarePR NewswireThe Department of Veterans Affairs Approves Purchase of FMCNA Products in Five Categories WALTHAM, Mass., Aug. 30, 2022 /PRNewswire/ -- Fresenius Medical North America's (FMCNA) Renal Therapies Group, the leading provider of kidney care products, wil
- 4y agoCTSOFMSCytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care PlatformsPR NewswireFresenius Medical Care and CytoSorbents have expanded their partnership via a multi-stage collaboration designed to seize new sales opportunities and jointly develop future innovations CytoSorb will be featured on Fresenius Medical Care's critical care
- 4y agoFMSFresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in DialysisPR NewswireCombiSet SMARTECH™ Offers Innovative New Design and Simplifies Use WALTHAM, Mass., July 27, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group today announced the availability of the CombiSet SMARTECHTM, the f
- 4y agoFMSHighmark Interactive Inc. Announces Collaboration with Renal Research Institute to Identify Potential Biomarkers of Brain Injury in Hemodialysis PatientsACCESS NewswireThe Renal Research Institute will include the Highmark digital assessment suite into its clinical research of people receiving in-center hemodialysis treatment. TORONTO, ON / ACCESSWIRE / June 20, 2022 / Highmark Interactive Inc. (TSXV:HMRK), a global l
- 4y agoFMSFDA Roundup: May 6, 2022FDA Press ReleasesToday, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA cleared the Spectrum Medical Quantum Heater-Cooler and the compatible Qura Quantum PureFlow Heat Exchangers used to warm or cool a patient during cardiopulmonary bypass procedures. Instead of using water, the Quantum Heater-Cooler device regulates the temperature of a gly ...
- 4y agoFMSFresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic RegistryPR NewswireGoal of 100,000 Participants Within Five Years to Help Scientists Better Understand Genetic Variations in Patients with Chronic Kidney Disease WALTHAM, Mass., April 13, 2022 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of produc
- 4y agoFMSFresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical OfficePR NewswireWALTHAM, Mass., April 5, 2022 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announced today the appointment of noted clinical researcher and nephrologist Nwamaka (Amaka
- 4y agoFMSFresenius Medical Care Holdings, Inc. et al. - Appeal, ReversedUS Patent Trial and Appeal Board
- 4y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, ReversedUS Patent Trial and Appeal Board
- 5y agoFMSFresenius Medical Care AG & Co KGaA (FMS) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsFMS earnings call for the period ending September 30, 2021.
- 5y agoFMSGIPRGeneration Income Properties Announces Agreement for Pending $3.1 Million TransactionACCESS NewswireTAMPA, FL / ACCESSWIRE / November 1, 2021 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIP" or the "Company") announced the signing of a definitive Purchase and Sale Agreement under which the Company will acquire an approximately 11,000 SF single
- 5y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 5y agoFMSFresenius Medical Care AG & Co KGaA (FMS) Q2 2021 Earnings Call TranscriptEarnings Call TranscriptsFMS earnings call for the period ending June 30, 2021.
- 5y agoFMSFresenius Medical Care Holdings, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 5y agoFMSFresenius Medical Care A G & Co. (FMS) Q1 2021 Earnings Call TranscriptEarnings Call TranscriptsFMS earnings call for the period ending March 31, 2021.
- 5y agoFMSDVAHealthcare Leader Jason Thomas Named President and COO of Central Ohio Urology GroupBusiness WireCOLUMBUS, Ohio--(BUSINESS WIRE)--Central Ohio Urology Group is pleased to announced that Jason Thomas has joined the practice as President and Chief Operating Officer. A seasoned healthcare executive with more than two decades of experience, Thomas has led the growth and development of several hundred medical clinics during his career.
- 5y agoFMSNew patent application published for: Systems and Methods for Delivery of Peritoneal Dialysis (pd) Solutions with Integrated Inter-Chamber DiffuserUS Patent Applications (USPTO)( 1 of 1 )